Skip to main content
Advertisement
Advertisement
APYX
APYX logo
Apyx Medical Corporation Common Stock
2.39
USD
Sponsored
-0.10
-4.02%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

2.36

-0.03
-1.21%

Apyx Medical Corporation Common Stock (APYX) Earnings

APYX Earnings Reports

Positive Surprise Ratio

APYX beat 31 of 44 last estimates.

70%

Next Report

Date of Next Report
Mar 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$19.57M
/
-$0.04
Implied change from Q3 26 (Revenue/ EPS)
+39.51%
/
--
Implied change from Q4 25 (Revenue/ EPS)
+2.14%
/
+33.33%

Apyx Medical Corporation Common Stock earnings per share and revenue

On Nov 05, 2026, APYX reported earnings of -0.04 USD per share (EPS) for Q3 26, beating the estimate of -0.09 USD, resulting in a 57.98% surprise. Revenue reached 14.03 million, compared to an expected 13.56 million, with a 3.50% difference. The market reacted with a +18.15% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.04 USD, with revenue projected to reach 19.57 million USD, implying an increase of 0.00% EPS, and increase of 39.51% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, Apyx Medical Corporation Common Stock reported EPS of -$0.04, beating estimates by 57.98%, and revenue of $14.03M, 3.5% above expectations.
The stock price moved up 18.15%, changed from $2.59 before the earnings release to $3.06 the day after.
The next earning report is scheduled for Mar 08, 2027.
Based on -- analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.04 and revenue of $19.57M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement